The Delta variant doubles the risk of hospitalization—but the vaccines still work

Link: https://www.technologyreview.com/2021/06/15/1026365/the-delta-variant-doubles-the-risk-of-hospitalization-but-the-vaccines-still-work/

Excerpt:

The good news? Vaccines still sharply reduce the risk of being admitted to hospital with the Delta variant. The Scottish study found that the Pfizer/BioNTech vaccine provided 79% protection, two weeks on from the second dose, while the Oxford/AstraZeneca vaccine offered 60% protection. That lower rate may be due to the fact that it takes longer for immunity to develop with the Oxford/AstraZeneca vaccine, researchers said. 

However, research released shortly after by Public Health England was even more promising. It found that the Pfizer/BioNTech vaccine provides 96% protection from hospitalization after two doses, while the Oxford/AstraZeneca is 92% effective at preventing hospitalization after both shots. The conclusion? It’s yet more evidence of the importance of making sure as many people as possible get vaccinated, and that they get both shots.

Author(s): Charlotte Jee

Publication Date: 15 June 2021

Publication Site: MIT Tech Review